Table 5.
Hazard ratio of MACE by LDL categories.
| Among PS matched cohort | MACE | MI | Ischemic stroke | CVD death | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (n = 44,616) | n | HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | ||||
| LDL < 70 mg/dL | 315 | 1.10 | 0.87 | 1.39 | 1.42 | 0.88 | 2.30 | 1.10 | 0.84 | 1.44 | 0.67 | 0.30 | 1.48 |
| (n = 4,616) | |||||||||||||
| 70 ≤ LDL < 100 mg/dL | 656 | 1.07 | 0.92 | 1.25 | 1.83 | 1.28 | 2.63 | 0.97 | 0.82 | 1.15 | 1.09 | 0.58 | 2.05 |
| (n = 10,861) | |||||||||||||
| 100 ≤ LDL < 130 mg/dL | 815 | 0.80 | 0.69 | 0.92 | 1.07 | 0.77 | 1.49 | 0.77 | 0.65 | 0.90 | 0.61 | 0.30 | 1.22 |
| (n = 13,377) | |||||||||||||
| 130 ≤ LDL < 160 mg/dL | 564 | 0.84 | 0.71 | 1.00 | 0.98 | 0.65 | 1.48 | 0.82 | 0.68 | 0.99 | 1.36 | 0.66 | 2.78 |
| (n = 10,401) | |||||||||||||
| 160 ≤ LDL < 190 mg/dL | 271 | 0.74 | 0.58 | 0.93 | 0.78 | 0.46 | 1.32 | 0.72 | 0.55 | 0.94 | 0.55 | 0.22 | 1.36 |
| (n = 5,361) | |||||||||||||
Hazard ratio (HR) was obtained with reference to the statin non-user group. CVD, cardiovascular disease; MACE, major adverse cardiovascular events, MI: myocardial infarction; CI, confidence interval; PS, propensity score.